Article info

Download PDFPDF
Therapeutic potency of IL2–caspase 3 targeted treatment in a murine experimental model of inflammatory bowel disease
  1. Dr H Lorberboum-Galski, Department of Cellular Biochemistry and Human Genetics, Hebrew University, Faculty of Medicine, Jerusalem 91120, Israel; hayag{at}ekmd.huji.ac.il
View Full Text

Citation

Shteingart S, Rapoport M, Grodzovski I, et al
Therapeutic potency of IL2–caspase 3 targeted treatment in a murine experimental model of inflammatory bowel disease

Publication history

  • Revised September 15, 2008
  • Accepted October 14, 2008
  • First published October 31, 2008.
Online issue publication 
May 11, 2009

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.